The Committee for Medicinal Products for Human Use recommends new requirements for manufacturing to eliminate nitrosamine impurities, giving a 'worst case' estimate of the associated cancer risk.
News Alerts
Original Article: New European Rules to Eliminate Carcinogens in Sartans